Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
Filed with HKEX · Stock code 2169 · · 10 pages · English
Summary by 6ix AI
The report confirms the total authorized share capital and provides details on issued shares and public float sufficiency. It also includes confirmations regarding compliance with listing rules and other regulatory requirements.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Canggang Railway Limited on 6ix
Earlier from Canggang Railway
- (1) Connected transaction in Relation to subscription of shares under Specific mandate and (2) application for Whitewash Waiver
- Interim Report 2026
- Nuance Pharma Announces Acceptance for Review of the New Drug Application for Ohtuvayre® (ensifentrine) by the National Medical Products Administration of China for the maintenance treatment of chronic obstructive pulmonary disease
Follow Canggang Railway into a list and get an email when it puts out news.
Follow Canggang Railway